YENOM NOTICIAS

Qué está moviendo el mercado.

Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.

DIM
Limpiar

Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.

finance.yahoo.comPOSITIVO

European Stocks Possibly Trading Below Estimated Value May 2026

As the European market navigates through a landscape marked by stable interest rates and geopolitical uncertainties, the pan-European STOXX Europe 600 Index has managed to maintain a steady course, reflecting cautious optimism amid positiv…

finance.yahoo.comPOSITIVO

3 European Stocks That May Be Trading Below Their Estimated Value

In the midst of geopolitical uncertainties and fluctuating energy prices, European markets have shown resilience with the pan-European STOXX Europe 600 Index gaining modestly. As investors navigate these complex conditions, identifying sto…

finance.yahoo.comPOSITIVO

Sartorius Shares Rise After Company Targets Top-Line, Profitability Growth

The laboratory products and services company expects group organic growth of 8% to 11% a year from 2027. Continue Reading

finance.yahoo.comPOSITIVO

Discover 3 European Stocks Believed To Be Trading Below Intrinsic Value

As European markets navigate the complexities of interest rate policies and trade uncertainties, indices like the STOXX Europe 600 have remained relatively stable, while major stock indexes in countries such as Italy and Germany have seen…

seekingalpha.comNEUTRAL

WisdomTree International MidCap Dividend Fund declares quarterly distribution of $0.5000

* WisdomTree International MidCap Dividend Fund (NYSEARCA:DIM [https://seekingalpha.com/symbol/DIM]) - $0.5000 [https://www.wisdomtree.com/etfs/equity/dim]. * 30-Day SEC Yield of 2.97% as of Sept. 24. * Payable Sep 29; for shareholders of…

investing.comPOSITIVO

Jefferies initiates coverage on Sartorius AG stock with Buy rating

Investing.com - Jefferies initiated coverage on Sartorius AG (ETR:SATG) (ETR:SRT) (OTC:SARTF) with a Buy rating and set a price target of EUR210.00. The research firm highlighted that investors can access Sartorius’ businesses through thre…

finance.yahoo.comPOSITIVO

3 European Stocks Estimated At Up To 41.3% Discount To Intrinsic Value

As European markets navigate the complexities of potential EU-U.S. trade deals and a slightly hawkish stance from the European Central Bank, investors are keenly observing opportunities that may arise from these developments. In this conte…

investing.comPOSITIVO

Sartorius H1 2025 presentation: Recurring business drives 6% growth, margin expansion

Introduction & Market Context Sartorius Group (FRA:SRT) presented its H1 2025 financial results on July 22, 2025, reporting a 6.1% constant currency sales growth and significant margin expansion despite continued softness in the equipment…

seekingalpha.comNEUTRAL

WisdomTree International MidCap Dividend Fund declares quarterly distribution of $1.4650

* WisdomTree International MidCap Dividend Fund (NYSEARCA:DIM [https://seekingalpha.com/symbol/DIM]) - $1.4650 [https://www.wisdomtree.com/etfs/equity/dim]. * Payable Jun 27; for shareholders of record Jun 25; ex-div Jun 25. MORE ON WISDOM…

finance.yahoo.comPOSITIVO

Resolutions of the Annual Shareholders' Meeting of Sartorius Stedim Biotech S.A.

AUBAGNE, France, March 29, 2022 /PRNewswire/ -- At today's combined Annual General Shareholders' Meeting of Sartorius Stedim Biotech S.A., shareholders passed the resolution to pay a dividend of 1.26 euros per share for fiscal 2021. The to…

finance.yahoo.comPOSITIVO

Evofem Biosciences to Present at H.C. Wainwright Global Life Sciences Conference

SAN DIEGO, Feb. 23, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it will present at the upcoming H.C. Wainwright Global Life Sciences Conference. Evofem's CEO, Saundra Pelletier, will provide an update on t…

finance.yahoo.comPOSITIVO

Evofem Biosciences to Report Fourth Quarter and Year-End 2020 Results and Provide Corporate Update on Thursday, March 4, 2021

-- Conference Call Scheduled for 4:30 p.m. ET -- -- Company to Provide Update on Commercial Launch of Phexxi and Pivotal Phase 3 Trial of EVO100 -- SAN DIEGO, Feb. 18, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) will hold…

finance.yahoo.comPOSITIVO

Evofem Biosciences Launches U.S. Direct-to-Consumer Campaign to Accelerate Awareness of Phexxi®, A Non-Hormonal Birth Control Option for Women

Marketing campaign includes the brand's first-ever commercial spot introducing women to a birth control that puts them in control of their body, their sex life, and their pregnancy prevention. SAN DIEGO, Feb. 16, 2021 /PRNewswire/ -- Evofe…